Humana Inc
NYSE:HUM
Relative Value
The Relative Value of one HUM stock under the Base Case scenario is 832.67 USD. Compared to the current market price of 320.71 USD, Humana Inc is Undervalued by 61%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
HUM Competitors Multiples
Humana Inc Competitors
Market Cap | P/S | P/E | P/B | ||||
---|---|---|---|---|---|---|---|
US |
Humana Inc
NYSE:HUM
|
38.6B USD | 0.4 | 19.4 | 2.4 | ||
US |
UnitedHealth Group Inc
NYSE:UNH
|
454B USD | 1.2 | 29.6 | 4.9 | ||
US |
Elevance Health Inc
NYSE:ELV
|
122.5B USD | 0.7 | 19.7 | 3 | ||
US |
Anthem Inc
NYSE:ANTM
|
116.4B USD | 0.8 | 18.6 | 3.2 | ||
US |
Centene Corp
NYSE:CNC
|
40.1B USD | 0.3 | 14.7 | 1.5 | ||
US |
Molina Healthcare Inc
NYSE:MOH
|
20B USD | 0.6 | 18.8 | 4.5 | ||
US |
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 6.8 | 121.4 | 3.3 | ||
BR |
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 3.2 | 45.6 | 4.6 | ||
BR |
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
28.9B BRL | 1.1 | -39 | 0.6 | ||
US |
Progyny Inc
NASDAQ:PGNY
|
3.1B USD | 2.8 | 49.3 | 5.5 | ||
US |
Magellan Health Inc
NASDAQ:MGLN
|
2.5B USD | 0.5 | 8.3 | 1.3 |